Regard vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

Andson Biotech leads in AI visibility (41 vs 31)
Regard logo

Regard

EmergingHealthcare

General

NYC healthcare AI clinical insights at $350M valuation Jul 2024 with 3M+ diagnoses surfaced and $50M+ incremental revenue for partners; $81.3M total ($61M Oak HC/FT Series B) serving Banner Health and Sentara competing with Nuance CDI.

AI VisibilityBeta
Overall Score
D31
Category Rank
#1006 of 1158
AI Consensus
75%
Trend
up
Per Platform
ChatGPT
36
Perplexity
26
Gemini
34

About

Regard is a New York-based healthcare AI company — backed with $81.3 million in total funding including a $61 million Series B in July 2024 led by Oak HC/FT with Cedars-Sinai Health Ventures at a $350 million valuation, following a $15.3 million Series A in 2022 and $5 million seed in 2021 — providing health systems with an AI clinical insights platform that analyzes 100% of hospitalized patient medical record data to surface missed diagnoses to care teams, acting as an AI co-pilot for physicians that has surfaced 3 million+ diagnoses and generated $50+ million in incremental revenue for health system partners through improved documentation accuracy. Founded in 2019 by Eli Ben-Joseph, Nate Wilson, and Thomas Moulia (Stanford graduate students) and launched in 2021, Regard serves major health systems including Banner Health (33 acute care hospitals) and Sentara Health (12 hospitals).

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

31
Overall Score
41
#1006
Category Rank
#220
75
AI Consensus
62
up
Trend
up
36
ChatGPT
49
26
Perplexity
36
34
Gemini
40
29
Claude
41
34
Grok
51

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.